Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

MUSTANG BIO, INC. Cash Flow Breakdown

Cash flow breakdown shows where MUSTANG BIO, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $5.26M went out.
  • Fiscal year ended 2025-12-31: from investing, $1.17M came in.
  • Fiscal year ended 2025-12-31: from financing, $14.53M came in.
  • Fiscal year ended 2025-12-31: change in cash, $10.43M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$5.26M$1.17M$0.00$14.53M*$10.43M
2024-12-31-$11.41M$0.00$0.00$6.51M$4.75M*-$145.00K
2023-12-31-$49.48M$5.89M-$30.38M$0.00$4.40M-$69.67M
2022-12-31-$65.07M-$2.95M$0.00$30.00M$206.00K$3.85M*-$33.96M
2021-12-31-$53.67M-$5.37M$0.00$309.00K$70.54M*$11.81M
2020-12-31-$37.32M-$4.41M$37.23M$40.89M*$36.39M
2019-12-31-$33.58M$13.91M$31.63M$33.49M*$45.44M
2018-12-31-$19.24M$557.00K$0.00-$18.51M
2017-12-31-$12.95M-$29.05M$49.98M*$7.98M
2016-12-31-$4.13M$0.00$31.63M*$27.50M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$967.00K*$0.00*
2026-03-31-$1.01M$0.00-$1.01M
2025-12-31-$1.72M*$0.00*$0.00*
2025-09-30-$818.00K*$0.00*$0.00*$7.14M*
2025-06-30-$1.34M*$0.00*$0.00*
2025-03-31-$1.39M$1.17M$0.00$7.62M*$7.39M
2024-12-31-$2.00M*$0.00*$0.00*$568.00K*$4.37M*
2024-09-30-$1.76M*$0.00*$0.00*$0.00*$1.01M*
2024-06-30-$2.33M*$0.00*$0.00*$5.27M*
2024-03-31-$5.32M$0.00$48.00K-$5.27M
2023-12-31-$7.25M*-$30.00K*$0.00*$0.00*$4.24M*
2023-09-30-$12.02M*$5.95M*$0.00*$0.00*$163.00K*
2023-06-30-$12.39M*-$34.00K*$0.00*$88.00K*-$30.38M*
2023-03-31-$17.81M$0.00$0.00$0.00-$17.81M
2022-12-31-$15.29M*-$420.00K*$0.00*$0.00*$0.00*
2022-09-30-$15.91M*-$892.00K*$0.00*$0.00*$90.00K*$710.00K*
2022-06-30-$17.57M*-$306.00K*$0.00*$0.00*$3.03M*
2022-03-31-$16.29M-$1.33M$30.00M$116.00K$12.60M
2021-12-31-$14.70M*-$1.48M*$0.00*$0.00*$4.92M*
2021-09-30-$11.29M*-$990.00K*$0.00*$151.00K*$3.08M*
2021-06-30-$12.10M*-$2.44M*$0.00*$0.00*$15.09M*
2021-03-31-$15.58M-$458.00K$0.00$158.00K$47.45M*$31.57M
2020-12-31-$9.47M*-$1.46M*$0.00*$33.49M*
2020-09-30-$10.12M*-$1.61M*$0.00*$1.62M*
2020-06-30-$7.57M*-$814.00K*$0.00*$37.93M*
2020-03-31-$10.15M-$526.00K$169.00K$4.91M*-$5.60M
2019-12-31-$9.49M*-$1.39M*$0.00*
2019-09-30-$8.83M*-$899.00K*$0.00*
2019-06-30-$8.78M*$4.20M*$9.13M*$42.49M*
2019-03-31-$6.48M$12.00M$22.50M-$8.89M*$19.13M
2018-12-31-$6.52M*$4.70M*$0.00*
2018-09-30-$3.80M*$10.35M*
2018-06-30-$3.36M*-$2.74M*
2018-03-31-$5.57M-$11.75M-$17.22M
2017-12-31-$5.17M*$7.43M*
2017-09-30-$4.77M*-$15.87M*-$20.58M*
2017-06-30-$974.00K*-$20.24M*
2017-03-31-$2.04M-$375.00K$49.92M*$47.51M
2016-12-31-$2.26M*$0.00*$18.64M*
2016-09-30-$565.00K*$0.00*$11.68M*$11.12M*
2016-06-30-$720.00K*$0.00*$720.00K*
2016-03-31-$581.00K$0.00$581.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B